Back to search

Rowan University

Molecular Pap Biomarkers for Cervical Cancer Risk Assessment in ThinPrep® Clinical Specimens

Abstract

dc:description.abstract

Approximately 500,000 patients are diagnosed with cervical cancer worldwide each year, thus making it the second most common cause of cancer-related deaths in women. Persistent high-risk human papillomavirus (HR-HPV) infections induce cervical dysplasia by increasing the expression of two viral oncogenes, E6 and E7. Utilization of the Papanicolaous smear test (Pap test) has contributed to a decrease in morbidity and mortality of cervical cancer; however, subjective analysis of cell morphology with a limited amount of cells has led to a substantial rate of false positive and false negative diagnoses. A more objective and sensitive diagnostic tool for the detection of true dysplastic or neoplastic cells in cervical tests would therefore avoid emotional distress for many patients and eliminate unnecessary pathology and follow-up care costs. This present study demonstrated that in situ hybridization (ISH) is a qualitative molecular diagnostic test for the detection of HPV E6/E7 DEK, CIP2A, Birc5, and PME-1 mRNA. This method distinguished each candidate biomarker in Hela and SiHa cell lines and detected down to 1 % of Hela cells in a heterogeneous population. The method was compared to polymerase chain reaction (PCR), and after assessing the results, the comparison showed an exceptional agreement. Further optimization of the ISH method is needed if it is to be able to detect biomarker mRNA expression in clinical ThinPrep samples. Such a clinical assay would allow for earlier detection of precancerous lesions in patient populations and the prevention of cancer progression.

Degree

thesis:*
Name thesis:degree_name
Master of Science in Molecular Pathology and Immunology
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Molecular Biology

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Taylor, Jennifer
Contributors dc:contributor
  • Salvatore Caradonna, PhD
  • Lisa Huang, PhD
  • Jason Trama, PhD

Subjects

dc:subject × 15

Identifiers

dc:identifier.*
Repository record dc:identifier
https://rdw.rowan.edu/gsbs_etd/72

Chain of custody

source
Harvested from
Rowan University
Base URL
rdw.rowan.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Taylor, Jennifer. Molecular Pap Biomarkers for Cervical Cancer Risk Assessment in ThinPrep® Clinical Specimens. Thesis thesis, https://rdw.rowan.edu/gsbs_etd/72